CDK4/6-IN-9
CDK4/6-IN-9 (compound 10) is a selective CDK4/6 inhibitor with an IC50 of 905 nM for CDK6/cyclin D1. CDK4/6-IN-9 has the potential for multiple myeloma (MM) research[1].
Product Specifications
CAS Number
2688098-02-2
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk4-6-in-9.html
Concentration
10mM
Purity
99.46
Solubility
DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CN1C=C(C2=NC(NC3=NC=C(CN4CCNCC4)C=C3)=NC=C2F)C5=CC=CN=C51
Molecular Formula
C22H23FN8
Molecular Weight
418.47
References & Citations
[1]Kai Yuan, et al. Discovery of novel and orally bioavailable CDK 4/6 inhibitors with high kinome selectivity, low toxicity and long-acting stability for the treatment of multiple myeloma. Eur J Med Chem. 2022 Jan 15;228:114024.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK4; CDK6
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
18434126 3x 1.0µg DNA
DND1 CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details 
T9390 1x106 cells / 1.0 mL
KAT7 CRISPR Knockout C3H/10T1/2 Stable Cell Line-T1-5
Sign In for Pricing
View Details ARP48165_P050-FITC 100 µL
LOC100360413 Antibody - middle region : FITC (ARP48165_P050-FITC)
Sign In for Pricing
View Details 
K6986404 1.0 µg DNA
Ptpre sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details